BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36247089)

  • 21. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis.
    Zhou R; Liu D; Zhu J; Zhang T
    Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma.
    Chen H; Yang J; Wu W
    BMC Cancer; 2021 Jul; 21(1):852. PubMed ID: 34301206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis.
    Ye Q; Lei L; Aili AX
    Eur J Gynaecol Oncol; 2015; 36(3):283-9. PubMed ID: 26189254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 26. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
    Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
    Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential gene drivers of cutaneous squamous cell carcinoma: Analysis of microarray data.
    Zheng Y; Chi S; Li C
    Medicine (Baltimore); 2020 Sep; 99(39):e22257. PubMed ID: 32991423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.
    Zhang L; Qin H; Wu Z; Chen W; Zhang G
    Int J Dermatol; 2018 Oct; 57(10):1208-1217. PubMed ID: 30105812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
    Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
    J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis.
    Li C; Hong Z; Ou M; Zhu X; Zhang L; Yang X
    Biomed Res Int; 2021; 2021():6673655. PubMed ID: 34734085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome analyses identify hub genes and potential mechanisms in adenoid cystic carcinoma.
    Liu HB; Huang GJ; Luo MS
    Medicine (Baltimore); 2020 Jan; 99(2):e18676. PubMed ID: 31914060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of key candidate genes involved in melanoma metastasis.
    Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
    Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.